… 65 low-dose (30mg once-daily) edoxaban with VKAs in AF … edoxaban 96 treatment in
non-valvular AF patients, and (2) … risks of SSE with apixaban, 251 rivaroxaban, and dabigatran …

… the risk of MB, low-dose DOACs, generally rivaroxaban 15mg or … risk of TE and MB versus
warfarin; (2) Compared to warfarin, non-… Apixaban in patients at risk of stroke undergoing atrial …

… Bleeding risk of apixaban, dabigatran, and low-dose rivaroxaban compared with warfarin in
Japanese patients … of administrative claims data. Curr Med Res Opin 2017;33:1955–63. [12…

… DOACs (apixaban, rivaroxaban, dabigatran) vs warfarin, Cox … Loire Valley Non-valvular AF
Project and studied 8,962 patients (… of low dose DOACs in patients with a high risk of bleeding …

… the Apixaban versus Warfarin in Patients with Atrial Fibrillation (… evaluation of stroke risk in
Asian patients with non-valvular AF. … In this study, the number of patients in dabigatran 150 mg …

… (dabigatran, rivaroxaban and apixaban) or warfarin in the year following hospitalization, but
could not have used any OAC one year prior to this claim. … bleeds among warfarin, low dose …

… of factor Xa (apixaban, edoxaban, and rivaroxaban) or of thrombin (dabigatran). RCTs have
… Haemorragic and thromboembolic risk in CKD patients with non valvular atrial fibrillation: do …

… anticoagulants including dabigatran, rivaroxaban, apixaban, … Low-dose dabigatran,
rivaroxaban, apixaban, and edoxaban … stroke in patients with non-valvular atrial fibrillation and no …

… of this study DOAC dose was stratified as “low” (dabigatran 75 … apixaban compared with
warfarin, which our results agreed with. We found rivaroxaban to significantly increase the risk of …